Skip to content
DefDex

Federal award

BAYER HEALTHCARE PHARMACEUTICALS INC

HT940623F0023

Contract

Obligated and Ceiling

Obligated (net)
$113,547.78
Ceiling (potential value, not spending)
$113,547.78
Current value
$113,547.78
Gross positive obligations
$113,547.78

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
BAYER HEALTHCARE PHARMACEUTICALS INC · V1EVGCK7XES8
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
BAYER AKTIENGESELLSCHAFT · NG4MKLABMVJ5
Awarding agency
Department of War · sub-agency 97DH · office HT9406
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
PIID
HT940623F0023
Parent vehicle (IDV PIID)
36F79720D0237
Award type code
C
Actions
2 · Feb 16, 2023 to Sep 30, 2023
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History2

Award actions
DateFYModAction typeObligationCompany in company totals
Sep 30, 2023FY2023P00001M$0.00
—
Feb 16, 2023FY20230—$113,547.78
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.